(16384177), T. P. D., (16384180), K. W. E., (15107821), M. G. R., (16384183), M. Z., (16384186), Y. Q. R., (16384189), X. Z., . . . (10258780), F. M. (2025). Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
Citazione stile Chigago Style (17a edizione)(16384177), Timothy P. DiPeri, et al. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. 2025.
Citatione MLA (9a ed.)(16384177), Timothy P. DiPeri, et al. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5 from Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers. 2025.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.